FDA authorizes remdesivir as emergency treatment for COVID-19
FDA authorizes remdesivir as emergency treatment for COVID-19
May 01, 2020
The FDA has granted authorization to Gilead Sciences for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19.
Post A Comment:
0 comments:
Leave a comment. Thanks!